1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Performance of the composite and 4D-CT MGD scores for predicting multigland disease
No. of Patients Sensitivity Specificity Positive Predictive Value Composite MGD score ≥1 28 100% 5% 41% ≥2 26 93% 16% 42% ≥3 24 86% 51% 53% ≥4 22 79% 72% 65% ≥5 13 46% 86% 68% 6 6 21% 100% 100% 4D-CT MGD score ≥0 28 100% 0% 39% ≥1 28 100% 26% 47% ≥2 23 82% 60% 58% ≥3 21 75% 74% 66% 4 9 32% 88% 64%